204 related articles for article (PubMed ID: 34824220)
1. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.
Rogic A; Pant I; Grumolato L; Fernandez-Rodriguez R; Edwards A; Das S; Sun A; Yao S; Qiao R; Jaffer S; Sachidanandam R; Akturk G; Karlic R; Skobe M; Aaronson SA
Nat Commun; 2021 Nov; 12(1):6889. PubMed ID: 34824220
[TBL] [Abstract][Full Text] [Related]
2. IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.
Mohamed HT; El-Ghonaimy EA; El-Shinawi M; Hosney M; Götte M; Woodward WA; El-Mamlouk T; Mohamed MM
Toxicol Appl Pharmacol; 2020 Aug; 401():115092. PubMed ID: 32512068
[TBL] [Abstract][Full Text] [Related]
3. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
6. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
Tu W; Gong J; Zhou Z; Tian D; Wang Z
Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast cancer biology: the tumour microenvironment is key.
Lim B; Woodward WA; Wang X; Reuben JM; Ueno NT
Nat Rev Cancer; 2018 Aug; 18(8):485-499. PubMed ID: 29703913
[TBL] [Abstract][Full Text] [Related]
8. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
Reddy JP; Atkinson RL; Larson R; Burks JK; Smith D; Debeb BG; Ruffell B; Creighton CJ; Bambhroliya A; Reuben JM; Van Laere SJ; Krishnamurthy S; Symmans WF; Brewster AM; Woodward WA
Breast Cancer Res Treat; 2018 Sep; 171(2):283-293. PubMed ID: 29858753
[TBL] [Abstract][Full Text] [Related]
9. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ; Li J; Zhang H; Kitamura T; Zhang J; Campion LR; Kaiser EA; Snyder LA; Pollard JW
Nature; 2011 Jun; 475(7355):222-5. PubMed ID: 21654748
[TBL] [Abstract][Full Text] [Related]
10. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
[TBL] [Abstract][Full Text] [Related]
11. A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
Zhang M; Zhou K; Wang Z; Liu T; Stevens LE; Lynce F; Chen WY; Peng S; Xie Y; Zhai D; Chen Q; Shi Y; Shi H; Yuan Z; Li X; Xu J; Cai Z; Guo J; Shao N; Lin Y
Cancer Res; 2024 Jun; 84(11):1781-1798. PubMed ID: 38507720
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory breast cancer (IBC): clues for targeted therapies.
Fernandez SV; Robertson FM; Pei J; Aburto-Chumpitaz L; Mu Z; Chu K; Alpaugh RK; Huang Y; Cao Y; Ye Z; Cai KQ; Boley KM; Klein-Szanto AJ; Devarajan K; Addya S; Cristofanilli M
Breast Cancer Res Treat; 2013 Jul; 140(1):23-33. PubMed ID: 23784380
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
[TBL] [Abstract][Full Text] [Related]
14. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
15. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors.
Hamm CA; Moran D; Rao K; Trusk PB; Pry K; Sausen M; Jones S; Velculescu VE; Cristofanilli M; Bacus S
Mol Cancer Ther; 2016 Jul; 15(7):1746-56. PubMed ID: 27196778
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
18. Differential Gene Expression of fresh tissue and patient-derived explants' matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1.
Tarek A; Mohamed HT; El-Sharkawy AA; El-Sayed SK; Hirshon JM; Woodward WA; El-Shinawi M; Mohamed MM
QJM; 2023 May; 116(5):345-354. PubMed ID: 36592055
[TBL] [Abstract][Full Text] [Related]
19. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.
Mohamed MM; El-Ghonaimy EA; Nouh MA; Schneider RJ; Sloane BF; El-Shinawi M
Int J Biochem Cell Biol; 2014 Jan; 46():138-47. PubMed ID: 24291763
[TBL] [Abstract][Full Text] [Related]
20. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]